<DOC>
	<DOC>NCT00162292</DOC>
	<brief_summary>The purpose of this clinical research study is to learn if it is safe for rheumatoid arthritis patients to take BMS-582949 along with methotrexate.</brief_summary>
	<brief_title>Multiple Ascending Dose Study of BMS-582949 in Patients With Stable Rheumatoid Arthritis on the Methotrexate Background</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>Age 1870 years Diagnosis of RA for â‰¥6 months Swollen or tender joint or ESR &gt;ULN. Subject must be on stable doses of MTX Women of Childbearing Potential Serum transaminase levels &gt;ULN CK&gt;ULN Cannot have taken Orencia or Remicade within 8 weeks of baseline, Humira or Enbrel within 4 weeks of baseline Use of H2 blockers or Proton Pump inhibitors while on study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2008</verification_date>
</DOC>